Key result
Natriuretic peptides regulate cardiovascular homeostasis via receptors with guanylyl cyclase activity.
This review highlights the discovery and structural characteristics of the natriuretic peptide family and their potential as therapeutic agents.
Answers are grounded in this paper and cite their sources.
May guide natriuretic peptide-targeted therapies in cardiovascular disease; extends molecular insights but leaves clinical translation open.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wilkins et al. (1993) reported a review. Natriuretic peptides was evaluated. The natriuretic peptide family, including ANP, BNP, CNP, and urodilatin, has been identified as a key contributor to cardiovascular homoeostasis mediated by receptors with guanylyl cyclase activity.
Synapse has enriched 10 related papers. Consider them for comparative context: